BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 38716625)

  • 1. Diacylglycerol kinase alpha is a proliferation marker of intrahepatic cholangiocarcinoma associated with the prognosis.
    Shichi S; Sugiyama K; Asahi Y; Shirakawa C; Nakamoto H; Kimura S; Wakizaka K; Aiyama T; Nagatsu A; Orimo T; Kakisaka T; Taketomi A
    Cancer Med; 2024 May; 13(9):e7238. PubMed ID: 38716625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.
    Benson AB; D'Angelica MI; Abrams T; Abbott DE; Ahmed A; Anaya DA; Anders R; Are C; Bachini M; Binder D; Borad M; Bowlus C; Brown D; Burgoyne A; Castellanos J; Chahal P; Cloyd J; Covey AM; Glazer ES; Hawkins WG; Iyer R; Jacob R; Jennings L; Kelley RK; Kim R; Levine M; Palta M; Park JO; Raman S; Reddy S; Ronnekleiv-Kelly S; Sahai V; Singh G; Stein S; Turk A; Vauthey JN; Venook AP; Yopp A; McMillian N; Schonfeld R; Hochstetler C
    J Natl Compr Canc Netw; 2023 Jul; 21(7):694-704. PubMed ID: 37433432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Roles of Diacylglycerol Kinase α in Cancer Cell Proliferation and Apoptosis.
    Sakane F; Hoshino F; Ebina M; Sakai H; Takahashi D
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy for hepatocellular carcinoma with diacylglycerol kinase alpha inhibition and anti-programmed cell death-1 ligand blockade.
    Okada N; Sugiyama K; Shichi S; Shirai Y; Goto K; Sakane F; Kitamura H; Taketomi A
    Cancer Immunol Immunother; 2022 Apr; 71(4):889-903. PubMed ID: 34482409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DGKA Mediates Resistance to PD-1 Blockade.
    Fu L; Li S; Xiao W; Yu K; Li S; Yuan S; Shen J; Dong X; Fang Z; Zhang J; Chen S; Li W; You H; Xia X; Kang T; Tan J; Chen G; Yang AK; Gao Y; Zhou P
    Cancer Immunol Res; 2021 Apr; 9(4):371-385. PubMed ID: 33608256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report of the 21st Nationwide Follow-up Survey of Primary Liver Cancer in Japan (2010-2011).
    Kudo M; Izumi N; Kokudo N; Sakamoto M; Shiina S; Takayama T; Tateishi R; Nakashima O; Murakami T; Matsuyama Y; Takahashi A; Miyata H; Kubo S
    Hepatol Res; 2021 Apr; 51(4):355-405. PubMed ID: 33382910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and Epitope Mapping of Anti-Diacylglycerol Kinase α Monoclonal Antibody DaMab-8 for Immunohistochemical Analyses.
    Sano M; Kaneko MK; Suzuki H; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2020 Feb; 39(1):1-5. PubMed ID: 31099705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diacylglycerol kinase α-selective inhibitors induce apoptosis and reduce viability of melanoma and several other cancer cell lines.
    Yamaki A; Akiyama R; Murakami C; Takao S; Murakami Y; Mizuno S; Takahashi D; Kado S; Taketomi A; Shirai Y; Goto K; Sakane F
    J Cell Biochem; 2019 Jun; 120(6):10043-10056. PubMed ID: 30536880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of tumor localization on the outcomes of surgery for an intrahepatic cholangiocarcinoma.
    Orimo T; Kamiyama T; Mitsuhashi T; Kamachi H; Yokoo H; Wakayama K; Shimada S; Nagatsu A; Taketomi A
    J Gastroenterol; 2018 Nov; 53(11):1206-1215. PubMed ID: 29721628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Survival of Recurrent Intrahepatic Cholangiocarcinoma: The Impact and Selection of Repeat Surgery.
    Yoh T; Hatano E; Seo S; Okuda Y; Fuji H; Ikeno Y; Taura K; Yasuchika K; Okajima H; Kaido T; Uemoto S
    World J Surg; 2018 Jun; 42(6):1848-1856. PubMed ID: 29218465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent.
    Zhang XF; Beal EW; Bagante F; Chakedis J; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
    Br J Surg; 2018 Jun; 105(7):848-856. PubMed ID: 29193010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel diacylglycerol kinase α-selective inhibitor, CU-3, induces cancer cell apoptosis and enhances immune response.
    Liu K; Kunii N; Sakuma M; Yamaki A; Mizuno S; Sato M; Sakai H; Kado S; Kumagai K; Kojima H; Okabe T; Nagano T; Shirai Y; Sakane F
    J Lipid Res; 2016 Mar; 57(3):368-79. PubMed ID: 26768655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection.
    Spolverato G; Kim Y; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Clark Gamblin T; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Tran TB; Wallis Marsh J; Pawlik TM
    Ann Surg Oncol; 2016 Jan; 23(1):235-43. PubMed ID: 26059651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment for intrahepatic cholangiocarcinoma in Europe: a single center experience.
    Bektas H; Yeyrek C; Kleine M; Vondran FW; Timrott K; Schweitzer N; Vogel A; Jäger MD; Schrem H; Klempnauer J; Kousoulas L
    J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):131-7. PubMed ID: 25159731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diacylglycerol kinase alpha enhances hepatocellular carcinoma progression by activation of Ras-Raf-MEK-ERK pathway.
    Takeishi K; Taketomi A; Shirabe K; Toshima T; Motomura T; Ikegami T; Yoshizumi T; Sakane F; Maehara Y
    J Hepatol; 2012 Jul; 57(1):77-83. PubMed ID: 22425622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.
    DeOliveira ML; Cunningham SC; Cameron JL; Kamangar F; Winter JM; Lillemoe KD; Choti MA; Yeo CJ; Schulick RD
    Ann Surg; 2007 May; 245(5):755-62. PubMed ID: 17457168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of diacylglycerol metabolism impairs the induction of T cell anergy.
    Olenchock BA; Guo R; Carpenter JH; Jordan M; Topham MK; Koretzky GA; Zhong XP
    Nat Immunol; 2006 Nov; 7(11):1174-81. PubMed ID: 17028587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes.
    Weber SM; Jarnagin WR; Klimstra D; DeMatteo RP; Fong Y; Blumgart LH
    J Am Coll Surg; 2001 Oct; 193(4):384-91. PubMed ID: 11584966
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.